13/12/2022

EuropaBio Principles for Genetic Testing and Testing for Genetically-Driven Risk Factor

European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.
28/11/2022

Enabling Patient Access to Transformational Therapeutic Innovations: Modernising the EU’s Cross-Border Healthcare Framework

European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.
23/11/2022

Innovation, Investment, and Excellence for Healthcare Biotechnology: Achieving a competitive environment in Europe | EuropaBio Healthcare BioForum, October 2022

EuropaBio hosted its inaugural Healthcare BioForum on October 5, 2022. The roundtable brought together representatives from SMEs, large companies, DGs GROW, Santé and RTD, European Parliament and Member States to discuss links between innovation, investment, and excellence in European healthcare biotechnology.
16/11/2022

Policy Proposal for New Genomic Techniques – Joint Letter to the EU Vice-President Frans Timmermans and the EU Commissioner Stella Kyriakides

European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.
11/11/2022

The Revision of the Orphan Medicines Regulation Is an Opportunity. Will Europe Seize it?

20/10/2022

Ensuring the full potential of EHDS: Stakeholders’ recommendations on how to make the digital transformation a success across Europe

19/10/2022

#EFIB2022:  Industrial biotechnology community comes together in Vilnius next week

06/10/2022

EuropaBio celebrates its inaugural Healthcare BioForum

04/04/2022

EuropaBio NAC Summit 2022: key recommendations on how National associations can deliver Europe’s innovation, investment and excellence in biotechnology

26/10/2021

Healthy Planet, Healthy People: a Pathway for Green Transition in the Biopharmaceutical Ecosystem

30/09/2021

Artificial intelligence: investing in new technologies in healthcare

What if machine learning and artificial intelligence could learn to detect one of the most common forms of blood cancer, through evaluating data based on the gene activity of blood cells?
07/06/2021

EuropaBio invited healthcare biotech SMEs to learn about EU Policy Priorities

27/05/2021

EuropaBio welcomes the EU strategy on Covid-19 therapeutics

27/04/2021

EuropaBio proposes how to increase competitiveness of biotechnology sector in the EU

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
16/04/2021

Online Roundtable Report: An EU Vision For Life Science and Biotechnology for a Healthy and Sustainable EU

Webinar Report.
22/03/2021

EuropaBio and P-BIO launch the National Associations Council Summit 2021 – Building on Biotechnology: from vaccines to Economic Growth for Europe

EuropaBio and P-BIO launch the National Associations Council Summit 2021 - Building on Biotechnology: from vaccines to Economic Growth for Europe
24/02/2021

European Health Emergency Preparedness and Response Authority (HERA) Consultation – EuropaBio’s Feedback

On February 24th, EuropaBio submitted its feedback to the HERA Consultation.
29/01/2021

Building a European Health Union

EuropaBio welcomes the European Health Union plan. The EU has indeed a critical role to play in public health and better crisis preparedness to address serious cross-border health threats and improving crisis management capacity.
03/08/2020

Joint Statement on the Health Innovation Partnership Proposal

Health industry sectors, representing pharmaceutical and medical technology companies welcome the publication of the Partnership Proposal as a significant milestone towards a European Partnership for Health Innovation.
30/07/2020

Joint response of EuropaBio and BIO on the EU Data Strategy Consultation

Joint response of EuropaBio and BIO on the EU Data Strategy Consultation.